Since p53 plays a crucial role in suppression of PTEN-deficient tumorigenesis via control of PTEN transcription [35], we propose that activation of p53 by resveratrol is likely to have chemopreventive efficacy in patients diagnosed with PTEN-deficient prostate cancer. This evidence concerns the gene TP53 and prostate cancer.